Gapping up
In reaction to strong earnings/guidance: DRWI +23%, AMBA +3.4%, BF.B +2.3%.
M&A news: PL +18.2% (Dai-ichi Life to acquire Protective Life for $70 per share), LM +7% (Stifel (SF) announces agreement to acquire Legg Mason Investment Counsel; terms were undisclosed), THRD -HALTED - (acquired by National Penn (NPBC) for $42/share).
Other news: NSTG +15.4% (entered into biomarker companion diagnostic Collaboration with Celgene (CELG)), DXCM +5.3% (received FDA approval for its Dexcom G4 PLATINUM Professional CGM), NQ +4.8% (reports on the Special Committee's Independent Investigation; the Investigation Team did not find evidence that the Company's revenues were inconsistent with public disclosures), DVR +4.7% (announces sale of its US Gulf of Mexico surface diving fleet for $18.5 mln), PGRX +4.6% (disclosed that Karlsson will not extend date to prepay debt; co has no cash available and terminated all but CEO; exploring alternatives, which may result in a bankruptcy filing), VVTV +3.7% (Cannell Capital discloses 5.6% active stake in 13D filing), YNDX +3.7% (still checking),FSLR +2.5% (India dumping case deferred to July 7, according to reports), MNKD +2.4% (cont momentum), IDCC +2.4% (pushing Apple (AAPL) for patent agreement, according to reports).
Analyst comments: EXAS +2.9% (initiated with a Buy at Goldman), RXN +2.3% (upgraded to Overweight from Equal Weight at Barclays), XL +1.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley), UA +1.6% (upgraded to Buy from Hold at Jefferies), GNC +1.5% (initiated with Buy at BofA), ANDE +0.8% (upgraded to Outperform from Neutral at Macquarie)